Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 175 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Specified Drug-use Surveillance of Fabhalta Capsules

Paroxysmal Nocturnal Hemoglobinuria Japan

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Healthy Volunteers, Pulmonary Arterial Hypertension Phase1, Phase2 Australia
Latvia
Portugal
Romania
United States
View all

An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).

Systemic Lupus Erythematosus, SLE Phase1 China
Germany
Hungary
Netherlands
Spain
Switzerland
View all

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Sickle Cell Disease Phase3 Colombia
United States

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) Greece
Ireland
Israel
Poland
Portugal
Romania
Russia
South Korea
Taiwan
United States
View all

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis Phase3 Argentina
Austria
Belgium
Brazil
Bulgaria
Chile
China
Colombia
Croatia
Denmark
Georgia
Guatemala
Hong Kong
India
Ireland
Israel
Italy
Jordan
Latvia
Lebanon
Lithuania
Malaysia
Mexico
Netherlands
Poland
Saudi Arabia
Slovakia
Spain
Switzerland
Taiwan
Turkey (Türkiye)
United Arab Emirates
United Kingdom
United States
View all

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Plaque, Atherosclerotic Phase4 China

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Argentina
Austria
Bulgaria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View all

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis Phase4 Colombia
Egypt
Peru
Turkey (Türkiye)
Vietnam
View all

Home Reported Outcomes in PNH

Paroxysmal Nocturnal Hemoglobinuria United States